Re: [MOL] New to list. [00817] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Re: [MOL] New to list.



David is right - of all the places I've been on the web, this one is the
best.  So many good people here and David found some very encouraging info
for me and my dad.  With people who can relate to what your going through,
even if it's just shedding a few tears!  Thanks David.
Lisa

----- Original Message -----
From: Whipps, David <David.Whipps@equitas.co.uk>
To: <mol-cancer@meds.com>
Sent: Thursday, September 14, 2000 7:04 AM
Subject: FW: [MOL] New to list.


> Hi Sal
> I think your've found one of the best places on the Web.  I'm sure someone
> will be able to give some help and advice.  I'll have a search around the
> Web for you, but unlike many here on the forum, my personal advice comes
> from the UK, so not too relevant to the medical practices in the States
and
> Canada.
>
> Welcome to one of the best groups in the world.
>
> -----Original Message-----
> From: Sal92273@aol.com [mailto:Sal92273@aol.com]
> Sent: 14 September 2000 13:58
> To: mol-cancer@lists.meds.com
> Subject: [MOL] New to list.
>
>
> Hello everyone,
>
> My name is Sal.  My mom has just been diagnosed with Stage III adeno
> carcinoma of the lungs.
>
> The whole experience is new to my family and I was wondering if anyone out
> there has advice.  She is to start her taxol + chromoplatin cycles next
> Wednesday, 9/20.  We don't know what to expect.  The doctor has opted
> against
> radiation for now.
>
> Also, I''ve been informed that Thalidimide may be helpful.  Any words?
>
> Thanks in advance,
>
> Sal.
> ------------------------------------------------------------------------
> This is an automatically-generated notice.  If you'd like to be removed
> from the mailing list, please visit the Medicine-On-Line Discussion Forum
> at <http://www.meds.com/con_faq.html>, or send an email message to:
> majordomo@lists.meds.com
> with the subject line blank and the body of the message containing the
line:
> unsubscribe mol-cancer your-email-address
> where the phrase your-email-address is replaced with your actual email
> address.
> ------------------------------------------------------------------------
>
>
> **********************************************************************
>     Equitas Limited            33 St Mary Axe, London, EC3A 8LL, UK
> NOTICE:   This message is intended only for use by the named addressee
> and may contain privileged and/or confidential information. If you are
> not the named addressee you should not disseminate,   copy or take any
> action in reliance on it.   If you have received this message in error
> please notify postmaster@equitas.co.uk  and delete the message and any
> attachments accompanying it immediately.
> Registered in England: Registered No. 3173352 Registered address above
> **********************************************************************
> ------------------------------------------------------------------------
> This is an automatically-generated notice.  If you'd like to be removed
> from the mailing list, please visit the Medicine-On-Line Discussion Forum
> at <http://www.meds.com/con_faq.html>, or send an email message to:
> majordomo@lists.meds.com
> with the subject line blank and the body of the message containing the
line:
> unsubscribe mol-cancer your-email-address
> where the phrase your-email-address is replaced with your actual email
> address.
> ------------------------------------------------------------------------

------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------